Ezedoc
✅ Lowers Cholesterol Levels
✅ Reduces Heart Disease Risk
✅ Prevents Atherosclerosis
✅ Prescribed by Doctors
✅ Oral Medication Option
Ezedoc contains Ezetimibe.
✓ Medisch beoordeeld door Morgan Ellis — Apotheekonderzoeker · 8 jaar ervaring · Laatst beoordeeld: mei 2026
⚡ Quick Answer — What is Ezedoc?
Ezedoc bevat ezetimibe (10 mg), a cholesterol-absorption inhibitor that blocks the NPC1L1 transporter in the small intestine. It is the go-to add-on therapy when a statin alone doesn’t get LDL to target. On its own, ezetimibe lowers LDL-C by about 17–22%. Added to a statin, it produces an additional ~20–25% LDL reduction, totaling a 55–60% fall — equivalent to doubling the statin dose without the dose-related muscle or liver side effects. The IMPROVE-IT trial (18,144 patients post-ACS) proved that adding ezetimibe to simvastatin further reduces cardiovascular events. Dose: 10 mg once daily, any time, with or without food. Generally very well-tolerated — mild GI upset, occasional myalgia, rare transaminase elevation. Avoid in severe hepatic impairment.
📦 Elke bestelling is gedekt door onze Reshipment Assurance Policy — als uw pakket niet binnen 20 werkdagen arriveert, sturen wij het opnieuw.
Waarom bestellen bij MedsBase
Onze generieke medicijnen zijn afkomstig van WHO-GMP gecertificeerde fabrikanten en worden wereldwijd verzonden in discrete, eenvoudige verpakkingen — geen medicijnnaam op de buitenkant van het pakket. Betalingen met kaart worden verwerkt via een gereguleerde processor (betalingsoverzichten vermelden een gereguleerde kaartbetalingprocessor — nooit “MedsBase” of een medicijnnaam). Crypto en SEPA bankoverschrijvingen worden ook geaccepteerd. Elke bestelling wordt ondersteund door ons Reshipment Assurance Policy.
What Is Ezedoc?
Ezedoc is an oral lipid-lowering medicine containing ezetimibe (10 mg), manufactured by WHO-GMP certified manufacturer. Supplied in packs of 30, 60, 90 or 180 tablets. Ezetimibe is the first and only drug of the cholesterol-absorption inhibitor class. Originator brand: Zetia / Ezetrol (Merck, 2002).
Ezetimibe is a mainstay of second-line lipid management — the first choice when you need more LDL reduction than a tolerated statin dose provides, or when a patient cannot tolerate higher statin doses. It is also the most common partner in fixed-dose combinations (simvastatin/ezetimibe = Inegy/Vytorin; rosuvastatin/ezetimibe = various).
What Is Ezedoc Used For?
- Primary hypercholesterolaemia — as add-on to a statin when LDL is not at goal on the maximum tolerated statin dose
- Statin intolerance — as monotherapy or with a very low statin dose when a full statin dose causes muscle or liver problems
- Familiale hypercholesterolemie (heterozygous and homozygous) — in combination with statin
- Secondary prevention after acute coronary syndrome — add to statin to further reduce CV events (IMPROVE-IT trial)
- Sitosterolaemia — a rare genetic condition where ezetimibe is disease-modifying
Ezetimibe is weak as a monotherapy (~17% LDL reduction) compared to a statin (~30–60%); it is most powerful as an add-on.
How Does Ezedoc Work?
Ezetimibe selectively inhibits the Niemann-Pick C1-Like 1 (NPC1L1) transporter on enterocytes in the proximal small intestine. NPC1L1 is responsible for absorbing dietary and biliary cholesterol from the gut lumen into the enterocyte.
With NPC1L1 blocked:
- Intestinal cholesterol absorption falls by ~54%
- Hepatic cholesterol stores decrease because less cholesterol reaches the liver
- LDL receptors are upregulated on hepatocytes — the liver pulls more LDL out of the blood
- Plasma LDL-C falls by 17–22% as monotherapy; up to 25% additional when combined with a statin
- HMG-CoA reductase activity (the statin target) is unchanged
Because ezetimibe and statins act on complementary pathways (absorption vs synthesis), their effects are additive. Statins reduce LDL synthesis; ezetimibe reduces LDL absorption/input. Together they drop LDL more than either can alone, without adding to each other’s side-effect profile.
Outcome data: the IMPROVE-IT trial (2015) showed adding ezetimibe to simvastatin in post-ACS patients reduced the composite CV endpoint by 6.4% (NNT 50 over 7 years), confirming that the LDL-lowering translates into real event reduction.
Dosering en toediening
Standaard dosering: 10 mg once daily at any time of day, with or without food.
- Take at a consistent time for adherence.
- Can be taken at the same time as a statin or spaced out — no timing interaction.
- Miss a dose — take it as soon as you remember unless close to the next; do not double up.
- No dose adjustment needed for renal impairment or mild-to-moderate hepatic impairment.
- Monitor lipid panel and ALT at baseline and 6–8 weeks after starting. Check CK only if symptoms.
Bijwerkingen
Ezetimibe is one of the best-tolerated lipid-lowering drugs. Adverse events are close to placebo rates in trials.
Common (< 5%):
- Mild diarrhoea, flatulence
- Upper respiratory tract infection, sinusitis
- Vermoeidheid
- Arthralgia
Minder vaak voorkomend:
- Transaminase elevation — usually small; more common when combined with a statin
- Muscle pain, myalgia, myopathy — rare; primarily when combined with statin
- Hypersensitivity, angioedema, rash
- Pancreatitis — very rare
- Cholelithiasis — very rare
- Thrombocytopenia — very rare
- Rhabdomyolysis — exceedingly rare, almost always in combination with a statin
Geneesmiddelinteracties
- Cyclosporine — significantly raises ezetimibe levels (and vice versa). Monitor cyclosporine levels; some guidance suggests avoiding.
- Bile acid sequestrants (cholestyramine, colestipol) — reduce ezetimibe absorption; take ezetimibe at least 2 hours before or 4 hours after.
- Warfarine — occasional INR change reported; monitor when starting.
- Statines — no adverse PK interaction; this combination is the therapeutic mainstay.
- Fibrates — fenofibrate/ezetimibe combination is safe; gemfibrozil raises ezetimibe levels and is generally avoided.
Who Should Not Take Ezedoc?
- Moderate-to-severe hepatic impairment (when combined with a statin)
- Active liver disease or persistent transaminase elevation > 3× ULN
- Pregnancy (when combined with a statin)
- Borstvoeding
- Children < 10 years (insufficient data)
- Known hypersensitivity to ezetimibe
Opslag
Store Ezedoc below 25°C in a dry place, in the original blister. Keep out of reach of children.
Veelgestelde vragen
Can I take Ezedoc instead of a statin?
Usually no. As monotherapy, ezetimibe lowers LDL by only ~17% — much less than a statin (30–60%). It is appropriate as monotherapy only for patients who cannot tolerate any statin at any dose. For most people, the best lipid-lowering strategy is statin first, ezetimibe added if LDL is still above target.
How does Ezedoc compare to doubling my statin dose?
Doubling a statin dose typically adds ~6% LDL reduction (the statin “rule of 6”). Adding ezetimibe adds ~20–25% LDL reduction. Adding ezetimibe is 3–4× more effective than doubling the statin, and without the dose-related rise in muscle symptoms. This is why modern guidelines favour statin + ezetimibe combination over pushing statin to maximum dose.
Does Ezedoc reduce heart attacks and strokes?
Yes — the IMPROVE-IT trial (18,144 post-ACS patients) showed adding ezetimibe to simvastatin reduced the composite endpoint of CV death, MI, unstable angina, revascularisation, or stroke by 6.4% over 7 years. This is the landmark evidence that LDL reduction beyond statins alone still translates into real cardiovascular benefit.
When should I take Ezedoc?
Any time of day is fine. Unlike simvastatin (evening preferred), ezetimibe timing is not dose-dependent — pick a time you will remember consistently. Many patients take it at the same time as their statin.
Does Ezedoc cause muscle pain like statins?
Rarely. Ezetimibe monotherapy shows placebo-level muscle side effects. When combined with a statin, it does not meaningfully increase statin-related muscle symptoms compared with the statin alone.
Where can I buy Ezedoc online?
You can order Ezedoc (10 mg) from MedsBase in packs of 30, 60, 90 or 180 tablets. We ship worldwide with discreet packaging and genuine WHO-GMP certified manufacturer stock.
Gerelateerde cholesterolmedicijnen
- Lipvas — Atorvastatin
- Crestor — Rosuvastatin 5/10/20 mg (AstraZeneca)
- Rosuline — Rosuvastatin
- Atorvatin — Atorvastatin
- Pivasta — Pitavastatin (interaction-clean)
- Lipicard — Fenofibrate (for triglycerides)
- Bekijk alle medicijnen tegen hoog cholesterol
Waarom bestellen bij MedsBase
Ezedoc is supplied through a WHO-GMP certified manufacturer with full COA documentation. We ship worldwide in plain, discreet packaging, and every order is covered by our Reshipment Assurance Policy. Uw betalingsbeschrijving bij betaling per kaart toont de gereguleerde betalingsverwerker (een gereguleerde kaartbetalingverwerker), nooit “MedsBase” of een medicijnnaam.
Gerelateerde alternatieven
Andere producten in Chronische aandoeningen die klanten ook bekijken:
Meer opties in behandelingen tegen hoog cholesterol
Gerangschikt op recente bestelvolumes van MedsBase — wat andere klanten in deze categorie kiezen.
| Sterkte | 10 mg |
|---|---|
| Hoeveelheid | 30 Tabletten, 60 Tabletten, 90 Tabletten, 180 Tabletten |
Ezedoc
Vragen & antwoorden
Ezedoc
Gerelateerde producten
Beoordelingen
Er zijn nog geen beoordelingen